| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.14B | 31.00B | 30.12B | 26.80B | 26.14B | 25.00B |
| Gross Profit | 11.22B | 10.36B | 10.17B | 9.06B | 9.37B | 8.91B |
| EBITDA | 5.24B | 5.29B | 5.12B | 4.34B | 4.53B | 4.38B |
| Net Income | -563.46M | 450.96M | 1.78B | 1.62B | 1.76B | 1.69B |
Balance Sheet | ||||||
| Total Assets | 41.64B | 38.66B | 38.58B | 36.92B | 35.56B | 36.34B |
| Cash, Cash Equivalents and Short-Term Investments | 11.27B | 12.31B | 9.45B | 7.57B | 12.21B | 13.08B |
| Total Debt | 2.34B | 2.71B | 3.08B | 3.34B | 3.47B | 4.29B |
| Total Liabilities | 15.10B | 13.64B | 13.00B | 12.48B | 12.11B | 12.88B |
| Stockholders Equity | 26.48B | 24.97B | 25.54B | 24.40B | 23.42B | 23.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.98B | 4.79B | 3.49B | 3.69B | 3.47B |
| Operating Cash Flow | 0.00 | 4.29B | 5.33B | 3.60B | 3.84B | 3.92B |
| Investing Cash Flow | 0.00 | 597.43M | -1.71B | -6.48B | -1.61B | -1.36B |
| Financing Cash Flow | 0.00 | -2.01B | -1.75B | -1.76B | -2.89B | -1.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥1.44T | 11.76 | 7.04% | 1.47% | 3.37% | -31.10% | |
74 Outperform | ¥1.29T | 11.67 | 6.28% | 1.07% | 3.01% | 6.48% | |
73 Outperform | ¥3.50B | 4.67 | ― | 1.93% | -1.00% | 105.56% | |
71 Outperform | ¥115.05B | 21.77 | 19.59% | 0.16% | 18.08% | 136.77% | |
68 Neutral | ¥42.24B | 7.42 | ― | 3.71% | -0.04% | 93.95% | |
67 Neutral | ¥28.57B | 38.52 | ― | 3.97% | 4.10% | -121.49% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |